Literature DB >> 18627646

Genes and irritable bowel syndrome: is there a link?

Yuri A Saito1.   

Abstract

Advances in genetics and genomics during the past decade, including sequencing of the human genome and DNA sequencing technologies, have made it possible to discover the genetic basis for many diseases. With the discovery of multiple genetic loci for gastrointestinal diseases such as Crohn's disease, some have begun to wonder-Could there be a genetic basis for irritable bowel syndrome (IBS)? This article summarizes the evidence for and against a link between genes and IBS. In addition, a gene-environment paradigm is presented to combine the two opposing hypotheses, as IBS may represent a complex genetic disorder that results from the interaction of several genes and environmental risk factors.

Entities:  

Mesh:

Year:  2008        PMID: 18627646      PMCID: PMC3935286          DOI: 10.1007/s11894-008-0069-9

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  54 in total

1.  Is health care seeking for irritable bowel syndrome and functional dyspepsia a socially learned response to illness?

Authors:  Natasha A Koloski; Philip M Boyce; Nicholas J Talley
Journal:  Dig Dis Sci       Date:  2005-01       Impact factor: 3.199

2.  Role of tumor necrosis factor-alpha and interleukin-10 gene polymorphisms in irritable bowel syndrome.

Authors:  Patrick P J van der Veek; Marlies van den Berg; Yvette E de Kroon; Hein W Verspaget; Ad A M Masclee
Journal:  Am J Gastroenterol       Date:  2005-11       Impact factor: 10.864

3.  Genetic influences in irritable bowel syndrome: a twin study.

Authors:  Imtiyaz Mohammed; Lynn F Cherkas; Stuart A Riley; Tim D Spector; Nigel J Trudgill
Journal:  Am J Gastroenterol       Date:  2005-06       Impact factor: 10.864

4.  Antibiotic use, childhood affluence and irritable bowel syndrome (IBS).

Authors:  M A Mendall; D Kumar
Journal:  Eur J Gastroenterol Hepatol       Date:  1998-01       Impact factor: 2.566

5.  A history of abuse in community subjects with irritable bowel syndrome and functional dyspepsia: the role of other psychosocial variables.

Authors:  Natasha A Koloski; Nicholas J Talley; Philip M Boyce
Journal:  Digestion       Date:  2005-08-25       Impact factor: 3.216

Review 6.  Functional bowel disorders.

Authors:  George F Longstreth; W Grant Thompson; William D Chey; Lesley A Houghton; Fermin Mearin; Robin C Spiller
Journal:  Gastroenterology       Date:  2006-04       Impact factor: 22.682

7.  Childhood sexual abuse and psychosomatic symptoms in irritable bowel syndrome.

Authors:  Colin A Ross
Journal:  J Child Sex Abus       Date:  2005

8.  Self-reported abuse and gastrointestinal disease in outpatients: association with irritable bowel-type symptoms.

Authors:  N J Talley; S L Fett; A R Zinsmeister
Journal:  Am J Gastroenterol       Date:  1995-03       Impact factor: 10.864

9.  Increased somatic complaints and health-care utilization in children: effects of parent IBS status and parent response to gastrointestinal symptoms.

Authors:  Rona L Levy; William E Whitehead; Lynn S Walker; Michael Von Korff; Andrew D Feld; Michelle Garner; Dennis Christie
Journal:  Am J Gastroenterol       Date:  2004-12       Impact factor: 10.864

10.  Evidence of a genetic contribution to functional bowel disorder.

Authors:  A Morris-Yates; N J Talley; P M Boyce; S Nandurkar; G Andrews
Journal:  Am J Gastroenterol       Date:  1998-08       Impact factor: 10.864

View more
  2 in total

1.  Neuropeptide s receptor induces neuropeptide expression and associates with intermediate phenotypes of functional gastrointestinal disorders (gastroenterology 2010;138:98-107).

Authors:  Jung Mook Kang
Journal:  J Neurogastroenterol Motil       Date:  2010-04-28       Impact factor: 4.924

2.  Neuropeptide S receptor induces neuropeptide expression and associates with intermediate phenotypes of functional gastrointestinal disorders.

Authors:  Michael Camilleri; Paula Carlson; Alan R Zinsmeister; Sanna McKinzie; Irene Busciglio; Duane Burton; Marco Zucchelli; Mauro D'Amato
Journal:  Gastroenterology       Date:  2009-09-02       Impact factor: 22.682

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.